Down syndrome (DS) is a genetic condition characterized by distinct facial features and developmental challenges, making early and accurate detection crucial for timely intervention and support. Traditional diagnostic methods often require specialized expertise, which can be resource intensive and inaccessible in many settings. In this study, we propose a novel artificial intelligence (AI)-driven approach to detecting DS using facial images, leveraging advancements in deep learning and machine learning for accurate and scalable diagnostics. A dataset of 168 facial images was curated from publicly accessible platforms, comprising 95 images of individuals without DS and 73 with the condition. The model was implemented using TensorFlow/PyTorch and employs RegNet X and Shifted Window Transformer (SWIN Transformer) for feature extraction, capturing both local and global facial features. To enhance feature representation, an attention-based fusion mechanism was applied, prioritizing the most discriminative patterns while filtering redundant information. For classification, an Extremely Randomized Tree (ExtraTrees) model was employed, known for its ability to efficiently handle high-dimensional data with strong generalization capabilities. The model was fine-tuned using Bayesian Optimization and Hyperband (BOHB), which optimized hyperparameters by balancing exploration and exploitation, thereby improving predictive performance. The final classification achieved a 99.2% accuracy with an area under the curve (AUC) of 1.00, demonstrating exceptional reliability in distinguishing DS from normal cases. By combining advanced feature extraction, fusion, and classification techniques, this study highlights the potential of AI to revolutionize DS diagnostics, offering a non-invasive, efficient, and scalable solution for early detection.
Down syndromeface classificationearly diagnosismodel interpretability
Advances in computational intelligence and robotics book series · 1-26
This chapter explores the profound impact of artificial intelligence (AI) on pharmaceutical research, particularly focusing on its integration into drug discovery, development, and clinical trial processes. The narrative details how AI-driven methodologies like predictive modeling, virtual screening, and machine learning revolutionize the identification and validation of drug targets and compounds. Additionally, the chapter discusses the application of AI in optimizing clinical trial designs, enhancing patient recruitment, and monitoring trial data in real-time. Ethical considerations including data privacy, bias, and the need for transparency in AI applications are critically analyzed to underscore the necessity for ethical guidelines and regulatory compliance in the evolving landscape of AI-driven pharmaceutical research. The comprehensive overview provided by the authors demonstrates how AI technologies not only accelerate drug development processes but also improve their efficacy, safety, and cost-efficiency.
drug discoverydrug developmentclinical trial designvirtual screening
Autism spectrum disorder (ASD) is a diverse neurodevelopmental condition with a significant genetic basis. Machine learning (ML) and deep learning (DL) models are emerging as powerful tools for identifying potential ASD risk genes and biomarkers to improve diagnostic accuracy. This narrative systematic review synthesizes evidence on the use of ML and DL models for ASD prediction and diagnosis, focusing on studies that utilized genetic variants and biomarkers. We conducted a systematic search across six databases [Web of Science, PubMed, Science Direct, Semantic Scholar, Institute of Electrical and Electronics Engineers (IEEE Xplore), and Association for Computing Machinery Digital Library (ACM-DL)] for articles published between 2009 and 2024, yielding 483 initial records. Multiple inclusion criteria were applied, and only peer-reviewed articles that used artificial intelligence, ML, or DL to predict ASD based on genetic biomarkers were included. After deduplication and applying inclusion and exclusion criteria, 14 studies were included in this review. These studies focused on genetic variants based on whole-genome sequencing, whole-exome sequencing, RNA sequencing, single-nucleus RNA sequencing, mRNA expression, long non-coding RNA, or single nucleotide polymorphism data. Our findings indicate that various ML models achieved robust performance, while DL architectures such as DeepASDPred outperformed ML models, with an accuracy of 93.8%. Most of the studies used datasets such as the Simons Foundation Autism Research Initiative (SFARI), the Simons Simplex Collection (SSC), the Autism Genetic Resource Exchange (AGRE), Atlas of the Developing Human Brain (BrainSpan), and the Simons Foundation Powering Autism Research for Knowledge (SPARK). The reviewed studies demonstrate that ML can help identify genetic risk factors and biomarkers that contribute to ASD. However, challenges remain, including data heterogeneity, small sample sizes, and the need for greater model interpretability. Addressing these challenges is crucial for translating ML models into clinically useful tools. In conclusion, DL substantially enhances ASD prediction, leveraging genetic data to identify novel candidate genes and support biological discovery of cell type-specific gene expression and roles of non-coding mutations in ASD.
Microscopy Research and Technique · مجلد 89 (5) · 687-704
Prostate cancer is a prevalent and serious health concern, ranking among the most frequently diagnosed cancers and a leading cause of cancer-related deaths in men worldwide. Early detection and accurate diagnosis are crucial for improving patient outcomes by limiting disease progression. Histopathological image analysis remains the gold standard for prostate cancer detection; however, manual interpretation is time-consuming and requires specialized expertise. To address these challenges, this study proposes a hybrid deep learning framework that combines an ensemble of transfer-learned CNNs (VGG-16, DenseNet-121, and AlexNet) with a fine-tuned Vision Transformer (ViT). The CNN ensemble extracts rich local features, while the ViT captures global contextual dependencies through a self-attention mechanism and a multilayer perceptron (MLP). Additionally, a cross-attention fusion (CAF) module integrates local and global features, and knowledge distillation (KD) enables a lightweight student network suitable for efficient clinical deployment. The study utilizes the publicly available PANDA dataset for training and testing. Preprocessing steps, including patch generation, gamma correction, and stain deconvolution, enhance image quality and feature representation. A comprehensive evaluation was conducted using standard performance metrics such as accuracy, true positive rate (TPR), true negative rate (TNR), precision, F1-score, false negative rate (FNR), and false positive rate (FPR). An ablation study confirmed the contribution of each module, highlighting the critical role of ensemble CNNs, CAF, and ViT in improving performance. Experimental results demonstrate that the proposed model outperforms conventional transfer learning models and existing state-of-the-art techniques, achieving 97.91% accuracy, along with significant improvements in TPR, TNR, and reduced FNR/FPR. The computational complexity, evaluated in terms of parameters, FLOPs, GPU memory, and inference time, indicates that the proposed model is more demanding than traditional CNNs. Nevertheless, the architecture strikes a practical balance between predictive accuracy and efficiency, making it suitable for real-world clinical applications. These findings underscore the potential of AI-powered hybrid models in expediting prostate cancer diagnosis and enabling timely intervention for improved patient outcomes.
prostate cancer detectionhistopathology image analysishybrid CNN-ViT modelcross-attention fusion
Hematological biomarkers have emerged as powerful tools in diagnosing Acute Heart Failure (AHF). This study introduces a novel diagnostic framework that integrates Explainable Artificial Intelligence (XAI) with Morris Sensitivity Analysis (MSA) to enhance both the interpretability and performance of machine learning models in AHF detection. A dataset consisting of 425 AHF patients and 430 controls was analyzed using eight machine learning models, including XGBoost, Histogram-based Gradient Boosting (histGB), Explainable Boosting Machine (EBM), and Random Forest. Model performance was evaluated through metrics such as AUC, accuracy, precision, recall, and Brier score. Hyperparameters were optimized via Bayesian optimization. Feature importance was assessed using MSA to identify variables with the highest predictive influence. The histGB model achieved the highest performance with an AUC of 87.93%. Both MSA and EBM consistently identified PDW, RDW-CV, NEU, NEU/LY ratio, age, and WBC as top predictive features across multiple models. These hematological markers demonstrated strong potential for early diagnosis and risk stratification in AHF patients. This study presents a clinically relevant, interpretable, and cost-effective diagnostic strategy that combines XAI with MSA for AHF prediction. The framework enhances clinical trust and provides a pathway toward personalized treatment by identifying accessible hematological biomarkers. The integration of explainability into AI models improves their transparency and applicability in real-world clinical settings.
Background and Objectives Hand and wrist fractures are among the most frequently encountered injuries in emergency departments and are often misdiagnosed, particularly when interpreted by non-specialist clinicians. These diagnostic errors can lead to treatment delays and long-term complications. Artificial intelligence (AI), particularly deep learning algorithms, is emerging as a promising adjunct to improve diagnostic accuracy in radiographic fracture detection. This study aims to evaluate the effectiveness of Artificial Intelligence (AI) in detecting hand and wrist fractures compared to manual radiographic interpretation by clinicians. Materials and Methods A systematic review and meta-analysis were conducted to assess the diagnostic performance of AI models in detecting hand and wrist fractures compared to conventional radiographic interpretation by clinicians. A comprehensive search of PubMed, Google Scholar, Science Direct, and Wiley Online Library was performed. Eligible studies included those utilizing AI for fracture detection with sensitivity and specificity data. Pooled estimates were calculated using fixed- and random-effects models. Heterogeneity was assessed via I 2 statistics, and publication bias was examined using funnel plots and Egger’s test. Results Eighteen studies met inclusion criteria. The pooled sensitivity and specificity under the random-effects model were 0.910 and 0.912, respectively, indicating high diagnostic accuracy of AI models. However, substantial heterogeneity (I 2 = 99.09% for sensitivity; 96.43% for specificity) and publication bias were observed, likely due to variations in AI algorithms, sample sizes, and study designs. Conclusions Most AI models demonstrated good diagnostic accuracy, with high sensitivity and specificity scores (≥90%). However, some models fell short in sensitivity and specificity (≤90%), indicating performance variations across different AI models or algorithms. From a clinical perspective, AI models with lower sensitivity scores may fail to detect hand and wrist fractures, potentially delaying treatment, while those with lower specificity scores could lead to unnecessary interventions—treating hands and wrists that are not fractured.
hand fractureswrist fracturesartificial intelligencedeep learning
Purpose In a period of rapid information dissemination, the spread of misinformation poses an important threat to public understanding and democratic processes. This study aims to examine the development of generative artificial intelligence (AI) models with the objective of automating the fact-checking of reports and reducing the impact of misinformation. Design/methodology/approach The study employed Bibliometrix R and VOS viewer tools to perform a thorough assessment of collaborative networks, research trends and important themes in the field of AI fact-checking journalism. The data was retrieved from the Scopus database that includes 282 publications between 2022 and 2024 to provide a bibliometric study on influence of AI on fact-checking in journalism. Findings The results show a notable increase in scholarly research output and examined the top prominent authors, active organizations and nations/countries that are advancing AI fact-checking in journalism research. The study identifies commonly explored key themes, such as automation, disinformation and ethical problems and co-authorship networks. Originality/value This study seeks to fill knowledge gaps by mapping the conceptual structure of AI tools in journalism articles, thereby offering an in-depth understanding of AI’s evolving influence in journalism ethics and fact-checking.
This article delves into the generative artificial intelligence (AI) project's complex ecosystem, with an emphasis on data architecture and model selection for optimal outcomes. Integrating generative AI into diverse academic and commercial domains brings unique challenges and opportunities. Navigating the generative AI project's environment is critical for success. The data architecture is complicated, so select your models wisely. This study seeks to provide complete guidelines to help manage these areas and ensure project success. Our technique consists of two fundamental components: a detailed data architecture research project for generative artificial intelligence is the first step toward identifying common problems and developing solutions. The next step is to analyze and contrast many generative models to see which ones work best for certain projects based on complexity, scalability, and ethics. Researchers verified solutions via case studies and expert talks. The findings highlight the need for a well-structured data infrastructure to boost generative AI endeavors. Studies have shown that carefully selecting generative models, taking into consideration project needs and constraints, results in better and more ethical solutions. To traverse the generative artificial intelligence project ecosystem, a comprehensive strategy must encompass ethical and technical data architecture construction as well as model selection. This study underlines the importance of understanding these issues and outlines a path forward for practitioners and researchers seeking to improve generational AI initiatives. To keep up with the fast progress of generative artificial intelligence, the study suggests further research and development in this area.
generative AIdata architecturemodel selectiondata infrastructure
Advances in computational intelligence and robotics book series · 275-302
Medication adherence remains a significant challenge within healthcare systems globally, especially among groups with chronic illnesses like diabetes, hypertension, and asthma. Despite universally accessible, low-cost Artificial Intelligence (AI) technologies to adherence, an information crevice exists on the utilization of this innovation and its effect on medicine self-efficacy and pharmaceutical adherence in therapeutically underserved populations with an assortment of persistent sicknesses. AI-enabled smartphone applications have surfaced as an encouraging remedy, presenting innovative methods to monitor patient behaviors, verify medication consumption, and deliver personalized reminders. By utilizing real-time monitoring, tailored communication, and behavioral nudges, AI can tackle the various barriers to medication adherence through creative solutions, including forgetfulness, lack of motivation, and insufficient health literacy, while fostering improved health outcomes, particularly among individuals with chronic conditions.
Advances in computational intelligence and robotics book series · 169-188
This chapter discusses the roles of digital biomarkers and artificial intelligence in enhancing precision therapeutics, which is the adaptation of treatments to a person's biomarker patterns for improving an individual's health. Digital biomarkers are collected from wearable technology and other digital devices that record variations in physiological and behavioral indexes thus improving disease diagnosis and treatment. This AI augments these biomarkers' prognostic accuracy and unearths patterns within large datasets within clinical settings; a major change to individualized care. This chapter in the book describes passive and active data acquisition in actual clinical scenarios and offers a conceptual foundation for employing digital biomarkers and artificial intelligence in trials. It also examines diagnostic image analysis and more specifically, the use of MRI to monitor Parkinson's disease, and EEG in managing mental health.
digital biomarkersartificial intelligenceprecision therapywearable devices
Advances in computational intelligence and robotics book series · 363-376
This chapter provides an overview of the history and impact of artificial intelligence on businesses, with a specific focus on the pharmaceutical industry and research. It discusses the basic principles of pharmacoeconomics, explores ways AI can enhance business processes, and examines various applications of AI in pharmaceutical research, such as drug development, digital therapy, personalized treatment, clinical trials, epidemic forecasting, and supply chain management. The chapter also addresses challenges and considerations related to ethics, safety, data privacy, and liability in AI implementation. Finally, the discussion provides insights into AI's economic opportunities and implications in pharmaceutical research.
artificial intelligencepharmaceutical industrypharmacoeconomicsdrug development
Human Behavior and Emerging Technologies · مجلد 2025 (1)
ASD (autism spectrum disorder) is a neurodevelopmental disorder affecting people’s social interaction, learning, and communication skills worldwide. It is a behaviorally distinct syndrome that is combined with several unknown and known disorders. The symptoms include sleep disorders, seizures, gastrointestinal tract symptoms, anxiety, wandering, hyperactivity/attention‐deficit disorder, and obesity. Hence, early detection of ASD is significant. However, clinically standardized screening tests are considered a prolonged diagnostic time, which is prone to errors and also leads to a rise in medical costs. Therefore, to decrease the time required for diagnosis and improve the precision of the model, AI (artificial intelligence) (machine learning (ML)) techniques are used to complement other traditional methods. Hence, this study has proposed a modified deep dynamic Levenberg–Marquardt (DDLM) optimized approach, which enhances the accuracy and classifier’s precision for implementing binary classification of children with ASD and children without ASD and tackles the issues in early detection. The process starts by preprocessing the data using label encoding and feature scaling techniques for eradicating irrelevant and noisy data, and then classification proceeds by utilizing the modified DDLM model. The dataset used in the proposed model is an amalgamation of datasets, which are ASD meta‐abundance and GSE113690_Autism_16S_rRNA. Additionally, a comparison of classifiers with three ML‐based algorithms, namely, MLP (multilayer perceptron), NB (naïve Bayes), and XGBoost (extreme gradient boost), is performed to analyze the effectiveness of the proposed system in the binary classification of ASD. The efficacy of the proposed system is evaluated using performance factors such as specificity, precision, F 1‐score, accuracy, and recall.
Advanced Health Science and Technology Journal · مجلد 1 (1) · 1-1
Welcome to the inaugural issue of the Advanced Health Science and Technology Journal (AHSTJ), a premier platform that brings together the most current and impactful research in health sciences and technology. It is with great pride and enthusiasm that we launch this journal, marking a significant milestone for AlMaarefa University and its commitment to advancing knowledge and innovation in the field of health care. As we embark on this exciting journey, the mission of AHSTJ is clear: to publish high-quality, peer-reviewed research that addresses the most pressing challenges and opportunities in health science and technology. In an era where the intersection of health care and technology is revolutionizing patient care, diagnostics, and treatment methods, AHSTJ aims to provide a space for cutting-edge research, groundbreaking discoveries, and thought leadership that will shape the future of the health sector. The healthcare landscape is evolving rapidly with advancements in medical technologies, artificial intelligence, telemedicine, bioinformatics, and personalized medicine. In this context, AHSTJ recognizes the importance of fostering collaboration between multidisciplinary experts, from healthcare professionals and researchers to engineers and technologists. This journal serves as a bridge that connects these diverse fields, fostering innovation, and cross-pollination of ideas. The research published in this inaugural issue reflects the breadth and depth of topics that will be explored in future volumes. From innovative medical devices to computational models and the ethical considerations in health tech, AHSTJ is dedicated to supporting and disseminating knowledge that drives positive change. The contributions from researchers and scholars across the globe provide a testament to the interdisciplinary nature of modern health sciences and technology. As we look to the future, AHSTJ is poised to become a vital resource for those at the forefront of medical research, healthcare delivery, and technology development. We invite readers, practitioners, researchers, and students to engage with the journal, share their insights, and contribute to the growing body of knowledge that will ultimately improve health outcomes worldwide. On behalf of the editorial team, we thank our contributors, reviewers, and readers for their support. We are excited to be part of this remarkable journey and look forward to the continued success of the AHSTJ.
health scienceshealth technologymedical devicesartificial intelligence in healthcare